Literature DB >> 12916979

Phosphorus-based SAHA analogues as histone deacetylase inhibitors.

Galina V Kapustin1, György Fejér, Jennifer L Gronlund, Dewey G McCafferty, Edward Seto, Felicia A Etzkorn.   

Abstract

[structure: see text] Three analogues of suberoyl anilide hydroxamic acid (SAHA) with phosphorus metal-chelating functionalities were synthesized as inhibitors of histone deacetylases (HDACs). The compounds showed weak activity for HeLa nuclear extracts (IC(50) = 0.57-6.1 mM), HDAC8 (IC(50) = 0.28-0.41 mM), and histone-deacetylase-like protein (HDLP, IC(50) = 0.33-1.9 mM), suggesting that the transition state of HDAC is not analogous to zinc proteases. Antiproliferative activity against A2780 cancer cells (IC(50) = 0.11-0.12 mM), comparable to SAHA (0.15 mM), was observed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12916979     DOI: 10.1021/ol035056n

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  12 in total

1.  Selenium-containing histone deacetylase inhibitors for melanoma management.

Authors:  Raghavendra Gowda; Subbarao V Madhunapantula; Dhimant Desai; Shantu Amin; Gavin P Robertson
Journal:  Cancer Biol Ther       Date:  2012-06-06       Impact factor: 4.742

2.  On the inhibition of histone deacetylase 8.

Authors:  Guillermina Estiu; Nathan West; Ralph Mazitschek; Edward Greenberg; James E Bradner; Olaf Wiest
Journal:  Bioorg Med Chem       Date:  2010-04-03       Impact factor: 3.641

3.  Homology modeling, force field design, and free energy simulation studies to optimize the activities of histone deacetylase inhibitors.

Authors:  Hwangseo Park; Sangyoub Lee
Journal:  J Comput Aided Mol Des       Date:  2004-06       Impact factor: 3.686

4.  Identification and functional significance of genes regulated by structurally different histone deacetylase inhibitors.

Authors:  Melissa J Peart; Gordon K Smyth; Ryan K van Laar; David D Bowtell; Victoria M Richon; Paul A Marks; Andrew J Holloway; Ricky W Johnstone
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-28       Impact factor: 11.205

5.  Structural requirements of HDAC inhibitors: SAHA analogs functionalized adjacent to the hydroxamic acid.

Authors:  Anton V Bieliauskas; Sujith V W Weerasinghe; Mary Kay H Pflum
Journal:  Bioorg Med Chem Lett       Date:  2007-02-08       Impact factor: 2.823

6.  The structural requirements of histone deacetylase inhibitors: SAHA analogs modified at the C5 position display dual HDAC6/8 selectivity.

Authors:  Ahmed T Negmeldin; Mary Kay H Pflum
Journal:  Bioorg Med Chem Lett       Date:  2017-06-13       Impact factor: 2.823

7.  Synthesis and biological evaluation of histone deacetylase inhibitors that are based on FR235222: a cyclic tetrapeptide scaffold.

Authors:  Erinprit K Singh; Suchitra Ravula; Chung-Mao Pan; Po-Shen Pan; Robert C Vasko; Stephanie A Lapera; Sujith V W Weerasinghe; Mary Kay H Pflum; Shelli R McAlpine
Journal:  Bioorg Med Chem Lett       Date:  2008-03-20       Impact factor: 2.823

8.  Substrate binding to histone deacetylases as shown by the crystal structure of the HDAC8-substrate complex.

Authors:  Alessandro Vannini; Cinzia Volpari; Paola Gallinari; Philip Jones; Marco Mattu; Andrea Carfí; Raffaele De Francesco; Christian Steinkühler; Stefania Di Marco
Journal:  EMBO Rep       Date:  2007-08-10       Impact factor: 8.807

Review 9.  Evolution of the arginase fold and functional diversity.

Authors:  D P Dowling; L Di Costanzo; H A Gennadios; D W Christianson
Journal:  Cell Mol Life Sci       Date:  2008-07       Impact factor: 9.261

10.  A phosphorylated prodrug for the inhibition of Pin1.

Authors:  Song Zhao; Felicia A Etzkorn
Journal:  Bioorg Med Chem Lett       Date:  2007-09-26       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.